Li Watsek
Stock Analyst at Cantor Fitzgerald
(0.22)
# 4,585
Out of 5,028 analysts
122
Total ratings
39.1%
Success rate
-9.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Li Watsek
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Maintained: Buy | $300 | $225.60 | +32.98% | 27 | Sep 28, 2026 | |
| NUVB Nuvation Bio | Initiated Coverage: Buy | $12 | $5.74 | +109.06% | 1 | Aug 21, 2026 | |
| ZLAB Zai Lab | Reiterated: Buy | $37 | $24.98 | +48.12% | 9 | Aug 6, 2026 | |
| REPL Replimune Group | Upgraded: Buy | n/a | $12.36 | - | 6 | Jul 31, 2026 | |
| ANL Adlai Nortye Group | Reiterated: Buy | n/a | $15.69 | - | 2 | Jul 16, 2026 | |
| IMRX Immuneering | Initiated Coverage: Buy | $17 | $4.27 | +298.13% | 1 | Jul 8, 2026 | |
| FTH Faeth Therapeutics | Reiterated: Buy | n/a | $28.00 | - | 2 | Jun 3, 2026 | |
| CRIS Curis | Rated: Hold | n/a | $0.8299 | - | 4 | Mar 27, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | n/a | $21.76 | - | 2 | Mar 4, 2026 | |
| AVBP ArriVent BioPharma | Initiated Coverage: Buy | n/a | $28.45 | - | 1 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.13 | - | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $24.97 | - | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.3457 | n/a | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.59 | n/a | 6 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.74 | n/a | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.76 | n/a | 8 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.62 | n/a | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.10 | n/a | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.28 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.31 | n/a | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.69 | n/a | 5 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $5.58 | n/a | 4 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $2.35 | n/a | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $0.015 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 → $38 | $2.75 | n/a | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $6 | $11.61 | n/a | 3 | Jun 28, 2022 |
Ascendis Pharma
Sep 28, 2026
Maintained: Buy
Price Target: $300
Current: $225.60
Upside: +32.98%
Nuvation Bio
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $5.74
Upside: +109.06%
Zai Lab
Aug 6, 2026
Reiterated: Buy
Price Target: $37
Current: $24.98
Upside: +48.12%
Replimune Group
Jul 31, 2026
Upgraded: Buy
Price Target: n/a
Current: $12.36
Upside: -
Adlai Nortye Group
Jul 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $15.69
Upside: -
Immuneering
Jul 8, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $4.27
Upside: +298.13%
Faeth Therapeutics
Jun 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $28.00
Upside: -
Curis
Mar 27, 2026
Rated: Hold
Price Target: n/a
Current: $0.8299
Upside: -
Tyra Biosciences
Mar 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $21.76
Upside: -
ArriVent BioPharma
Dec 22, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $28.45
Upside: -
Dec 3, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $1.13
Upside: -
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $24.97
Upside: -
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $0.3457
Upside: n/a
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $7.59
Upside: n/a
Sep 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $36.74
Upside: n/a
Jun 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $10.76
Upside: n/a
Jun 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $11.62
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.10
Upside: n/a
May 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $3.28
Upside: n/a
Jan 24, 2025
Reiterated: Buy
Price Target: n/a
Current: $1.31
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: n/a
Current: $3.69
Upside: n/a
Aug 30, 2023
Reiterated: Buy
Price Target: $11
Current: $5.58
Upside: n/a
Aug 9, 2023
Reiterated: Hold
Price Target: $5
Current: $2.35
Upside: n/a
Aug 7, 2023
Reiterated: Buy
Price Target: $8 → $5
Current: $0.015
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $71 → $38
Current: $2.75
Upside: n/a
Jun 28, 2022
Reiterated: Buy
Price Target: $16 → $6
Current: $11.61
Upside: n/a